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The KCNH2 gene encodes the Kv11.1 potassium channel that conducts the rapidly activating delayed rectifier
current in the heart. KCNH2 pre-mRNA undergoes alternative processing; intron 9 splicing leads to the formation
of a functional, full-length Kv11.1a isoform,while polyadenylationwithin intron 9 generates a non-functional, C-
terminally truncated Kv11.1a-USO isoform. The relative expression of Kv11.1 isoforms plays an important role in
the regulation of Kv11.1 channel function and the pathogenesis of long QT syndrome. In this study, we identified
cis-acting elements that are required for KCNH2 intron 9 poly(A) signal activity. Mutation of these elements
decreased Kv11.1a-USO expression and increased the expression of Kv11.1amRNA, protein and channel current.
More importantly, blocking these elements by antisense morpholino oligonucleotides shifted the alternative
processing of KCNH2 intron 9 from the polyadenylation to the splicing pathway, leading to the predominant
production of Kv11.1a and a significant increase in Kv11.1 current. Our findings indicate that the expression of
the Kv11.1a isoform can be upregulated by an antisense approach. Antisense inhibition of KCNH2 intronic
polyadenylation represents a novel approach to increase Kv11.1 channel function.
© 2014 Elsevier Ltd. All rights reserved.
1. Introduction
KCNH2 or human ether-a-go-go-related gene 1 (hERG1) encodes the
Kv11.1 channel that conducts the rapidly activating delayed rectifier
K+ current (IKr) in the heart [1–4]. Kv11.1 channels are essential for car-
diac action potential repolarization and mutations in KCNH2 cause long
QT syndrome type 2 (LQT2) [5]. Alternative intronic polyadenylation
has been shown to direct the expression of two Kv11.1 C-terminal
isoforms, the functional Kv11.1a isoform and the non-functional
Kv11.1a-USO isoform [6]. Kv11.1a is produced by splicing from exon 9
to exon 10 and use of a distal poly(A) site in exon 15, whereas
Kv11.1a-USO is generated by the activation of a proximal poly(A) site
within intron 9. The last 359 amino acids of Kv11.1a are absent in
Kv11.1a-USO and the truncated isoform fails to form functional channels
when expressed inmammalian cells [7–9].We recently reported a novel
LQT2mutation that disrupted the alternative processing of KCNH2 intron
9 and resulted in switching the expression of Kv11.1 isoforms from
Kv11.1a to Kv11.1a-USO [10]. Thus, the relative expression of Kv11.1a
and Kv11.1a-USO isoforms plays an important role in the regulation of
Kv11.1 channel function and the pathogenesis of LQT2.
The alternative processing of KCNH2 pre-mRNA is regulated by the
relative efficiencies of RNA splicing and polyadenylation events. These
events depend on interactions between trans-acting splicing and
polyadenylation factors and cis-acting elements present in KCNH2. The
poly(A) signal within KCNH2 intron 9 consists of a weak, noncanonical
hexamer, AGUAAA [6]. When this poly(A) signal is changed to the
strong, canonical poly(A) signal, AAUAAA, polyadenylation becomes
the dominant reaction, resulting in the predominant expression of
Kv11.1a-USO. The elimination of the intron 9 poly(A) signal by the
AGUAAA to CGCAAA mutations results in predominant expression of
Kv11.1a and an increase in channel current. Therefore, it is possible to
modulate the relative expression of Kv11.1a and Kv11.1a-USO by
manipulating the strength and the usage of the intron 9 poly(A) site.
In this study, we identified cis-acting elements that are required
for the intron 9 poly(A) signal activity. We then tested the hypo-
thesis that inhibition of these elements using antisense morpholino
oligonucleotides (MO) would decrease Kv11.1a-USO expression,
allowing a given transcript to be processed to the functional
Kv11.1a isoform. Our findings indicate that the expression of the
functional Kv11.1a isoform can be upregulated by antisense inhibi-
tion of KCNH2 intronic polyadenylation.
2. Materials and methods
2.1. Generation of the minigene luciferase reporter construct
The minigene luciferase reporter construct was generated by sub-
cloning the Renilla luciferase gene downstream of a splicing competent
KCNH2 minigene composed of KCNH2 genomic DNA from exon 8 to
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exon 11. The construction of the KCNH2minigene has been previously
described [11]. The N-terminus of the minigene was tagged by the
Myc epitope, which was inserted in-frame with the KCNH2 and lucifer-
ase translation sequence. Expression of theminigene luciferase reporter
is driven by a CMV promoter. The vector also contains the firefly lucif-
erase gene driven by the SV40 promoter, which was used as a control
for transfection efficiency. The deletion and mutations of U/GU-rich
elements downstream of the KCNH2 intron 9 poly(A) signal were
performed using the pAlter in vitro mutagenesis system (Promega,
Madison, WI). HEK293 cells were transiently transfected with the
minigene luciferase reporter construct using the Effectene method
(Qiagen, Valencia, CA). After 24 h, cells were harvested and assayed
for both firefly and Renilla luciferase activity using the Dual-
Luciferase assay kit (Promega). Data were analyzed by normalizing
Renilla luciferase activity to firefly luciferase activity and presented
as mean ± SEM.
2.2. Generation of the short KCNH2 gene and stable transfection in Flp-In
HEK293 cells
The generation of a short KCNH2 gene construct, in which the two
longest introns, intron 2 (14.9 kb) and intron 5 (4.4 kb),were shortened
to 600 bp has been previously described [10]. Mutations were intro-
duced into the short KCNH2 gene by the pAlter in vitromutagenesis sys-
tem (Promega). Stably transfected Flp-In HEK293 cells were generated
by the co-transfection of the KCNH2 gene constructs (0.1 μg) with the
Flp recombinase expression vector pOG44 (0.9 μg) using the Effectene
method and selected with 100 μg/ml hygromycin.
2.3. Generation of the tandem KCNH2 poly(A) signal construct
The generation of the tandem poly(A) signal construct was pre-
viously described [6]. The construct contained the SV40 promoter, the
firefly luciferase gene, and 308 bp of KCNH2 intron 9 followed by a syn-
thetic poly(A) signal. HEK293 cells were transiently transfected with
the tandem poly(A) construct as previously described [6].
2.4. Antisense MO treatment
MOs were synthesized by Gene Tools (Philomath, OR). The KCNH2
antisenseMOwas designed to target a 25 nt sequencewithin KCNH2 in-
tron 9 containing U/GU-rich elements (underlined) essential for the
activation of the intron 9 poly(A) signal, 5′-CAGAACACAGTAGTGAAT
CAAAACC-3′. The invert MO with the same sequence but in a reverse
orientation was used as a control. The Endo-Porter delivery system
(Gene Tools)was used to deliver antisense and invertMOs into the cells.
2.5. RNase protection assay
RNA isolation and theRNase protection assay (RPA)were performed
aspreviously described [6]. Briefly, antisense RNA riboprobeswere tran-
scribed in vitro in the presence of biotin-14-CTP. Yeast RNAwas used as
a control for the complete digestion of the probes by RNase. The relative
intensity of each bandwas quantified using ImageJ software and adjust-
ed for the number of biotin-labeled cytidines in each protected frag-
ment. The expression level of the hygromycin B resistance gene from
the KCNH2 gene constructs was used to normalize the relative expres-
sion of Kv11.1 isoforms.
2.6. Immunoblot analysis
Immunoblot analysis was performed as previously described [10].
The cell lysateswere subjected to SDS-polyacrylamide gel electrophore-
sis and then electrophoretically transferred onto nitrocellulose mem-
branes. The membranes were incubated with an anti-Kv11.1 antibody
against the N-terminus of Kv11.1a and Kv11.1a-USO proteins (H-175,
Santa Cruz, Santa Cruz, CA) at a 1:600 dilution and visualized with the
ECL detection kit (Amersham, Piscataway, NJ). The expression level of
hygromycin B phosphotransferase (HPH) encoded by hygromycin B
resistance gene was used as loading control [6].
2.7. Patch-clamp recordings
Membrane currents were recorded inwhole cell configuration using
suction pipettes as previously described [4]. The bath solution contained
(in mM) 137 NaCl, 4 KCl, 1.8 CaCl2, 1 MgCl2, 10 glucose, and 10 HEPES
(pH 7.4 with NaOH). The pipette solution contained (in mM) 130 KCl,
1 MgCl2, 5 EGTA, 5 MgATP, and 10 HEPES (pH 7.2 with KOH). All
patch-clamp experiments were performed at 22–23 °C. Kv11.1 current
was activated by depolarizing steps between−70 and +50 mV from
a holding potential of−80mVandKv11.1 tail currentwas recorded fol-
lowing repolarization to−50 mV. The patch-clamp data are presented
as mean± SEM and analyzed by Student's t-test. P b 0.05 is considered
statistically significant.
3. Results
3.1. Intron 9 poly(A) signal downstream elements are required for Kv11.1
alternative polyadenylation
Polyadenylation sites are primarily defined by a hexameric
poly(A) signal AAUAAA or other close variants [12]. In addition to the
poly(A) signal, the cis-acting, U/GU-rich downstream element (DSE) is
also required for the formation of the poly(A) tail. We have reported
that alternative polyadenylation within KCNH2 intron 9 is directed by
a noncanonical poly(A) signal AGUAAA [6]. To identify cis-acting ele-
ments required for intron 9 polyadenylation, we designed a reporter
construct by subcloning the Renilla luciferase gene downstream of a
splicing competent minigene composed of KCNH2 genomic DNA from
exon 8 to exon 11. In this KCNH2 reporter construct, the splicing of
intron 9 generated active luciferase and polyadenylation of intron 9
resulted in no luciferase activity (Fig. 1A).Wefirst deleted 107 nt down-
stream of the poly(A) signal in the minigene luciferase reporter con-
struct. The deletion significantly increased the luciferase activity,
suggesting that the downstream region contains elements that are
required for polyadenylation (Fig. 1B, d-DS). Analysis of the intron 9
sequence revealed several putative U/GU-rich elements that we refer
to as DSE-1, DSE-2 and DSE-3 (Fig. 1A). We mutated DSE-1 from
GUUUUG to CCACAA (Mut1), DSE-2 from UGUGUU to CAACCA (Mut2)
and DSE-3 fromUCUUU to CCAAC (Mut3) in theminigene luciferase re-
porter construct. Mut1 and Mut2, but not Mut3, significantly increased
the luciferase activity (Fig. 1B). When both DSE-1 and DSE-2 were mu-
tated (Mut1 + 2), the luciferase activity was further increased com-
pared to Mut1 and Mut2 alone. When both DSE-2 and DSE-3 were
mutated (Mut2 + 3), the luciferase activity was increased, but similar
to Mut2 alone. Together, these results suggest that DSE-1 and DSE-2
play a key role in KCNH2 intron 9 polyadenylation.
3.2. Regulation of Kv11.1 isoform expression by intron 9 poly(A) signal
downstream elements
To test the effects of the downstream elements in the regulation of
Kv11.1 isoform expression, we introduced the DSE-1 and DES-2 muta-
tions into the short KCNH2 gene construct (Fig. 2A) [10]. Wild-type
(WT) and mutant short gene constructs were stably transfected into
Flp-In HEK293 cells. The Mut1 and Mut2 mutations increased Kv11.1a
expression and decreased Kv11.1a-USO expression in RPA and immu-
noblot analyses (Figs. 2B, C).WhenbothDSE-1 andDSE-2weremutated
(Mut1 + 2) Kv11.1a was predominantly expressed. Patch-clamp stud-
ies showed that Kv11.1 channel current was significantly increased in
Mut1 + 2 (Fig. 2D). The maximum tail current densities of WT and
Mut1 + 2 were 7.0 ± 0.6 pA/pF (n = 9) and 17.8 ± 1.7 pA/pF (n =
Fig. 1. Identification of cis-acting elements required for intron 9 polyadenylation using a luciferase reporter construct. (A)Diagramof theKCNH2minigene luciferase reporter construct and
sequence of downstream elements of the KCNH2 intron 9 poly(A) signal. Downstream element deletion and mutations are indicated. (B) Histogram showing the effect of downstream
element deletion and mutations on luciferase activity (n = 3–6).
Fig. 2. Effect of DSE mutations on Kv11.1 isoform expression using the short KCNH2 gene construct. (A) The structure of the short KCNH2 gene construct and sequence of downstream
elements of the KCNH2 intron 9 poly(A) signal. DSE-1 and DSE-2 mutations are indicated. (B) RPA analysis of mRNA in Flp-In HEK293 cells stably expressing WT and DSE mutant short
KCNH2 genes. Signals of Kv11.1 isoforms were quantified and shown as a percentage of the total signal (1a + 1a-USO) (mean ± SD, n = 3). (C) Immunoblot analysis of Kv11.1 protein
expressed in cells expressingWT andDSEmutant shortKCNH2 genes. The expression level of hygromycin Bphosphotransferase (HPH) encoded byhygromycinB resistant gene served as a
loading control. Signals were quantified and shown as isoform percentage of total (1a + 1a-USO) Kv11.1 protein (mean ± SD, n = 3). (D) Representative currents recorded from cells
stably expressing WT and Mut1 + 2 short KCNH2 genes.
10, P b 0.001), respectively. These results suggest that DSE-1 and DSE-2
are important downstream elements of the intron 9 poly(A) signal, and
that disruption of these elements leads to a shift in KCNH2 pre-mRNA
processing toward the production of the Kv11.1a isoform and an
increase in Kv11.1 channel function.
3.3. Antisense MO inhibition of the KCNH2 intron 9 polyadenylation
Because DSE-1 and DSE-2 are important for KCNH2 intron 9
polyadenylation, we reasoned that blocking these elements using an
antisense approach would inhibit KCNH2 intron 9 polyadenylation and
lead to the upregulation of the functional Kv11.1a isoform.We designed
a 25-mer antisense MO complementary to the KCNH2 intron 9 down-
stream elements including DSE-1 and DSE-2 (Fig. 3A). To determine
whether the antisense MO can inhibit the poly(A) signal in intron 9,
we performed competition assay using a tandem poly(A) signal con-
struct as previously described [6]. The KCNH2 intron 9 poly(A) signal
AGUAAA and flanking sequences (−130/+172 nt) were positioned
upstream of a relatively strong synthetic poly(A) signal (Fig. 3A). We
treated the cells expressing the tandem poly(A) construct with 5 μM
invert or antisense MO and performed RPA analysis using a probe spe-
cific to 249 nt of KCNH2 intron 9 [6]. This probe will generate a 158 nt
fragment if the intron 9 poly(A) signal is used and a 249 nt fragment if
the synthetic poly(A) signal is utilized. In the presence of the invert
MO, the KCNH2 intron 9 poly(A) signal was predominantly used
(Fig. 3B). In the presence of the antisense MO against DSE-1 and DSE-
2, the transcription was predominantly terminated at the synthetic
poly(A) signal. Treatment with antisense MO resulted in a decreased
usage of the intron 9 poly(A) site from 83% to 41% and an increased
usage of the synthetic poly(A) site from 17% to 59% (n = 3, Fig. 3C).
These results indicate that antisense MO treatment inhibits the
poly(A) signal in KCNH2 intron 9.
3.4. Modulation of Kv11.1 isoform expression by antisense MO
To test whether the inhibition of intron 9 polyadenylation by MO is
able to modulate the relative expression of Kv11.1 isoforms, we treated
Flp-In HEK293 stably expressing short KCNH2 gene with antisense MO
against DSE-1 and DSE-2. RPA analysis showed that treatment with
5 μM antisense MO for 48 h resulted in an increase in the Kv11.1a
transcript and a decrease in the Kv11.1a-USO transcript compared to
the control invert MO (Fig. 4A). This result suggests that the relative
expression of Kv11.1 C-terminal isoforms can be modulated by an anti-
sense approach that targets the downstream elements of intron 9
poly(A) signal. To determine whether antisense MO-induced modula-
tion of Kv11.1 C-terminal isoform expression leads to the isoform
switch at the protein level, we analyzed Kv11.1 protein expression by
immunoblot. Flp-In HEK293 cells stably expressing short KCNH2 gene
were treated with different concentrations of antisense MO for 48 h or
with 5 μM for different times (Figs. 4B, C). Treatment with antisense
MO significantly increased the level of Kv11.1a protein and decreased
Kv11.1a-USO protein levels. AntisenseMO treatment exhibited concen-
tration and time dependence. The level of Kv11.1a protein increased
with 2 μM antisense MO and reached a maximum at 10 μM antisense
MO (Fig. 4B). The increase of the Kv11.1a protein level was observed
by 24 h and reached a maximum by 72 h following antisense MO treat-
ment (Fig. 4C).
3.5. Antisense MO treatment increased Kv11.1 channel current
To study the functional consequence of antisense MO-induced
isoform switch, we performed patch-clamp recordings of Kv11.1 chan-
nel current. Cells stably expressing the short KCNH2 gene were treated
with 10 μM antisense or invert MO for 48 h. Treatment with antisense
MO significantly increased Kv11.1 current compared to the invert MO
control (Fig. 5). The maximum tail current densities in invert and anti-
sense MO-treated cells were 7.6 ± 1.0 pA/pF (n = 8) and 16.8 ±
2.1 pA/pF (n = 9, P b 0.001, Fig. 5B), respectively. The voltage depen-
dence of Kv11.1 channel activation was determined by fitting the nor-
malized tail currents with a Boltzmann function (Fig. 5C). The half
maximal activation voltages (V1/2) for control and treatment with anti-
sense MO were−4.2 ± 2.9 mV and−5.6 ± 2.0 mV, respectively, and
the slope factor (k) for control and treatment with antisense MO were
8.7 ± 0.2 and 7.9 ± 0.3, respectively. These patch-clamp experiments
Fig. 3. Inhibition of theKCNH2 intron 9 poly(A) site by antisenseMO. (A) Diagramof the tandempoly(A) signal construct and the sequence of the antisenseMO. (B) RPA analysis of relative
usage of intron 9 poly(A) signal and synthetic poly(A) signal following the treatment with invert or antisense MO. (C) Quantitative analysis of RPA results (mean ± SD, n = 3).
demonstrated that inhibition of polyadenylation of intron 9 using anti-
sense MO can increase the functional expression of Kv11.1 channel
current.
3.6. Effect of antisense MO on Kv11.1 isoform expression in canonical
poly(A) signal construct
Wehave previously shown that the poly(A) signal in KCNH2 intron 9
is intrinsically weak due to the presence of the noncanonical hexamer
AGUAAA. When the intron 9 poly(A) signal AGUAAA was changed to
the canonical poly(A) signal AAUAAA, the Kv11.1a-USO isoform was
predominantly expressed [6]. To test whether the antisense MO is to
mediate the switch of the expression from Kv11.1a-USO to the
Kv11.1a isoform in the presence of a strong poly(A) signal, we treated
HEK293 cells stably expressing the short KCNH2 gene construct
containing the canonical poly(A) signal with inverted or antisense
MO. As shown in RPA analysis (Fig. 6A), in the presence of the inverted
MO, Kv11.1a-USO was predominantly expressed with no obvious
expression of Kv11.1a mRNA. When treated with 10 μM antisense MO,
the expression of the Kv11.1a isoform was significantly increased.
Immunoblot analysis revealed that the expression of the Kv11.1a iso-
form increased with the increased antisense MO concentrations
(Fig. 6B). Patch clamp studies showed that treatment with 10 μM anti-
senseMO significantly increased Kv11.1 current compared to the invert
MO control (Fig. 6C). The maximum tail current densities in invert and
antisense MO-treated cells were 1.3 ± 0.3 pA/pF (n = 8) and 11.5 ±
1.4 pA/pF (n = 9, P b 0.001), respectively. These results indicate that
antisense MO can mediate Kv11.1 isoform switch in the presence of a
strong intron 9 poly(A) signal. However, the relative efficiency of
Kv11.1 isoform switch is markedly reduced compared with the weak,
non-canonical poly(A) signal.
4. Discussion
In the present study, we identified two downstream U/GU-rich ele-
ments important for the intron 9 poly(A) signal activity. Mutations of
these elements resulted in the predominant production of Kv11.1a
and a marked increase in channel current. Furthermore, we found that
blocking these elements by antisenseMOdecreased the relative expres-
sion of the non-functional Kv11.1a-USO isoform and increased the ex-
pression of the functional Kv11.1a isoform. These results suggest that
the relative expression of Kv11.1 C-terminal isoforms can bemodulated
by inhibition of the intron 9 poly(A) signal with an antisense approach.
Ourfindings highlight antisenseMO-mediatedKv11.1 isoform switch as
a potential therapeutic approach for LQT2.
The KCNH2 intron 9 poly(A) site consists of a relatively weak, nonca-
nonical hexamer, AGUAAA. In addition to the noncanonical hexamer,
the KCNH2 intron 9 poly(A) site also contains a 22 nt “A” stretch imme-
diately following the AGUAAA hexamer. It has been reported that many
human noncanonical poly(A) sites contain A-rich sequences and have a
higher frequency of U and GU nucleotides in the downstream region
compared with canonical poly(A) sites [13]. These U/GU-rich down-
stream elements are critical for the efficient polyadenylation of nonca-
nonical poly(A) signals. In support of this notion, we identified two U/
GU rich downstream elements that play a critical role in KCNH2 intron
9 polyadenylation and showed that antisense MO targeting these ele-
ments can effectively inhibit KCNH2 intron 9 polyadenylation, leading
to the isoform switch from Kv11.1a-USO to Kv11.1a. The fact that anti-
sense MO is much less effective in the presence of a strong, canonical
poly(A) signal indicates that the downstream elements of the weak,
noncanonical poly(A) signal serve as ideal targets for antisense MO-
mediated inhibition of KCNH2 intron 9 polyadenylation.
Despite the presence of the weak poly(A) signal in KCNH2 intron 9,
polyadenylation is the dominant event in the heart, as about two-thirds
of KCNH2 pre-mRNA are processed to the non-functional Kv11.1a-USO
isoform in the heart [6,7]. We have shown previously that the balance
between splicing and polyadenylation, mediated by intrinsically weak
splicing and weak poly(A) signals, is important for the alternative pro-
cessing of KCNH2 pre-mRNA and the relative expression of Kv11.1a and
Kv11.1a-USO isoforms. Our present results demonstrate that inhibition
of intron 9 polyadenylation by the antisense approach can shift the
balance toward the splicing pathway, thereby leading to the
predominant expression of the full-length Kv11.1a isoform. A limitation
of this study is the use of HEK293 cells rather than cardiomyocytes. Al-
though the shortKCNH2 gene construct expressed inHEK293 cells exhib-
ited a similar expression pattern of Kv11.1 isoforms as in the heart, future
studies using cardiomyocytes will be necessary to confirm the antisense
MO-induced regulation of KCNH2 alternative polyadenylation.
The significance of thiswork is highlighted by our recentfinding that
a disease-causing KCNH2mutation, IVS9-2delA, resulted in the switch
from the functional Kv11.1a isoform to the non-functional Kv11.1a-
Fig. 4.Modulation of Kv11.1 isoform expression by antisense MO. (A) RPA analysis of the
effect of antisense MO on Kv11.1 isoform expression. Signals were quantified and shown
as an isoform percentage of the total signal (1a + 1a-USO, mean ± SD, n = 3).
(B) Immunoblot analysis showing concentration dependence of antisense MO effect.
Signals were quantified and shown as an isoform percentage of total (1a + 1a-USO)
Kv11.1 protein (mean ± SD, n = 3). (C) Time course of antisense MO effect. Signals
were quantified and shown as an isoform percentage of total (1a + 1a-USO) Kv11.1
protein (mean ± SD, n = 3).
USO isoform [10]. The antisense approach shown in the present work
would be an ideal strategy for correcting the isoform switching defect
caused by IVS9-2delA, as it can switch the isoform expression from
Kv11.1a-USO to Kv11.1a in the WT allele. The antisense MO strategy is
also suitable for the majority of nonsense and frameshift mutations
that are sensitive to the nonsense-mediated mRNA decay [14] as well
as many trafficking defective mutations that do not have a dominant
negative effect or have an incomplete dominant negative effect on the
WT channels [15,16]. For those mutations that have severe dominant
negative effects, the antisense approach is effective if mutant mRNA
can be downregulated by allele-specific RNA interference [17,18].
Thus, the antisense inhibition of intron 9 polyadenylation represents a
novel approach for the upregulation Kv11.1 channel current which
may have therapeutic applications across a wide spectrum of LQT2
mutations.
Alternative polyadenylation is increasingly recognized as an impor-
tant mechanism of gene regulation [12,19]. Alternative polyadenylation
can lead to the generation of alternate transcripts with different coding
sequences and/or variable 3′-untranslated regions. Furthermore, aber-
rant alternative polyadenylation has been associated with many
human diseases [19]. Thus, modulation of alternative polyadenylation
is of particular interest for the regulation of isoform expression with
potential therapeutic applications. Although antisense approaches
have been widely used in the downregulation of gene expression and
modulation of alternative splicing [20], antisensemodulation of alterna-
tive polyadenylation is only reported in a few cases including E-selectin
and receptor tyrosine kinases [21,22]. In the case of E-selectin, inhibition
of the 3′-most polyadenylation site by antisense oligonucleotides
results in the redirection of polyadenylation to one of two upstream
poly(A) sites and shortens the 3′-untranslated region. The shorter tran-
scripts generated following antisense treatment have fewer destabiliza-
tion sequences, thereby increasing mRNA stability [21]. Many receptor
tyrosine kinase genes undergo alternative intronic polyadenylation
that generates dominant negative, secreted isoforms. Inhibition of U1
snRNA binding by targeting the upstream 5′ splice sites with antisense
oligonucleotides can activate the intronic poly(A) sites and induce the
switch from the full-length,membrane bound receptor to the truncated,
soluble isoforms of receptor tyrosine kinases [22]. In contrast, antisense
inhibition of intronic poly(A) sites results in a decrease in the expression
of the soluble isoforms [22]. Our results demonstrate that antisenseMO-
induced inhibition of intronic poly(A) site not only reduces the truncat-
ed Kv11.1a-USO isoform but also increases the full-length Kv11.1a iso-
form. The present work is the first demonstration of using the
antisense approach tomodulate alternative polyadenylation that results
in a switch from the truncated isoform to the full-length isoform. Our
findings suggest that antisense MO may represent a useful strategy to
upregulate the expression of full-length isoforms of other genes that
are regulated by alternative intronic polyadenylation.
Fig. 5. Effect of antisense MO on Kv11.1 channel current. (A) Representative currents recorded from Flp-In HEK293 cells stably expressing short KCNH2 gene following treatment with
10 μM invert or antisense MO for 48 h. (B) I–V plot of tail current density measured at−50 mV following test voltages from−70 to +50 mV for invert (■) and antisense (●) MOs.
(C) Activation curves for invert (■) and antisense (●) MO treatments.
Fig. 6. Effect of antisenseMO on Kv11.1 isoform expression in canonical poly(A) signal construct. (A) RPA analysis of mRNA from cells stably expressing the short KCNH2 gene containing
the canonical poly(A) signal following the treatmentwith 10 μM invert or antisenseMO. Signalswere quantified and shown as an isoformpercentage of the total signal (1a+ 1a-USO, n=
3). (B) Immunoblot analysis showing concentration dependence of antisense MO effect. Signals were quantified and shown as an isoform percentage of total (1a + 1a-USO) Kv11.1
protein (mean ± SD, n = 3). (C) Representative currents recorded from Flp-In HEK293 cells stably expressing short KCNH2 gene containing the canonical poly(A) signal following
treatment with 10 μM invert or antisense MO for 48 h.
In summary, we have demonstrated that the relative expression of
Kv11.1 C-terminal isoform can be modulated using antisense MO,
resulting in the upregulation of the full-length functional Kv11.1a
isoform. These results suggest that antisense strategies targeting the
alternative polyadenylation of the KCNH2 gene may represent a novel
approach to increase Kv11.1 channel function.
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